Fernandez, J.L.C.; Benelli, R.; Costa, D.; Campioli, A.; Tavella, S.; Zocchi, M.R.; Poggi, A.
Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes. Cancers 2023, 15, 610.
https://doi.org/10.3390/cancers15030610
AMA Style
Fernandez JLC, Benelli R, Costa D, Campioli A, Tavella S, Zocchi MR, Poggi A.
Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes. Cancers. 2023; 15(3):610.
https://doi.org/10.3390/cancers15030610
Chicago/Turabian Style
Fernandez, Jordi Leonardo Castrillo, Roberto Benelli, Delfina Costa, Alessio Campioli, Sara Tavella, Maria Raffaella Zocchi, and Alessandro Poggi.
2023. "Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes" Cancers 15, no. 3: 610.
https://doi.org/10.3390/cancers15030610
APA Style
Fernandez, J. L. C., Benelli, R., Costa, D., Campioli, A., Tavella, S., Zocchi, M. R., & Poggi, A.
(2023). Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes. Cancers, 15(3), 610.
https://doi.org/10.3390/cancers15030610